Qiagen N.V. (QGEN)
After hours:
| Previous Close | 43.54 |
| Open | 43.15 |
| Bid | 43.39 x 1000 |
| Ask | 43.39 x 800 |
| Day's Range | 43.09 - 43.57 |
| 52 Week Range | 34.74 - 47.44 |
| Volume | |
| Avg. Volume | 1,284,881 |
| Market Cap | 9.683B |
| Beta (5Y Monthly) | 0.39 |
| PE Ratio (TTM) | 128.15 |
| EPS (TTM) | 0.34 |
| Earnings Date | Jul 31, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Jan 30, 2024 |
| 1y Target Est | 50.60 |
ZacksQIAGEN Launches QIAcuityDx Digital PCR System: Stock to Gain?
QGEN expands its digital PCR portfolio with the newly launched QIAcuityDx Digital PCR System. The system will be used for clinical testing in oncology across North America and Europe.
GlobeNewswireQIAGEN launches QIAcuityDx digital PCR system for clinical testing in oncology
Expands range of applications for successful QIAcuity digital PCR platforms, now entering the clinical space across North America and the EU // Provides absolute quantitation, essential for precise monitoring of low-abundance targets in clinical diagnostics // Enhances lab efficiency and reduces costs with all-in-one instrument for either IVD assays or tests designed and used by laboratories, user-friendly software and flexible scheduling featuresVenlo, the Netherlands, Sept. 30, 2024 (GLOBE NEW
Simply Wall St.Those who invested in Qiagen (NYSE:QGEN) five years ago are up 41%
When you buy and hold a stock for the long term, you definitely want it to provide a positive return. Better yet, you'd...
